| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |